Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Biosimilar-focused biopharmaceutical company and contract development and manufacturing organization (CDMO) Tanvex BioPharma has named Stephen Lam its new chief executive (CEO). 5 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
Ireland-incorporated biotech firm Alkermes has named Craig Hopkinson to the posts of chief medical officer, and senior vice president of clinical development and medical affairs. 31 May 2017
Shares in US biotech firm Alexion Pharmaceuticals slumped nearly 10% today as investors were unsettled by a raft of management changes from new chief executive Ludwig Hantson. 24 May 2017
Actelion has detailed changes to its management team that will come into effect once the Swiss biotech firm becomes part of Johnson & Johnson. 16 May 2017
Japan’s Astellas Pharma has promoted Shontelle Dodson to senior vice president and head of medical affairs Americas, effective May 15, 2017. Ms Dodson previously served as vice president of medical excellence within the global medical affairs organization. 12 May 2017
German family-owned drugmaker Grünenthal has appointed Mark Fladrich to the position of chief commercial officer (CCO) responsible for the firm’s entire global commercial organization. 9 May 2017
Cambridge, UK-based monoclonal antibody specialist Kymab Group today announced the appointment of Dr Sonia Quaratino as its first chief medical officer. Dr Quaratino will manage the clinical development of the group's expanding therapeutic antibody portfolio. 9 May 2017
US biotech Seattle Genetics has agreed to terminate its license agreement with Immunomedics for cancer drug candidate sacituzumab govitecan (IMMU-132) and settle the related litigation. 8 May 2017
Paris, France-based GenSight Biologics has appointed Mohamed Genead, the former head of ophthalmology/retina gene therapy at Biogen, as the company’s new chief medical officer. 4 May 2017
Bayer hA appointed Bhavesh Ashar as senior vice president and head of oncology for the company's Pharmaceuticals Division in the USA, reporting to Carsten Brunn, head of Bayer Pharmaceuticals for the Americas region. 3 May 2017
Private company ImCheck Therapeutics has raised 20 million euros ($22 million) to fund research into antibodies involved in the immune system. 3 May 2017
In the midst of a comprehensive cost cutting program rumored to include thousands of job losses, Teva chief financial officer Eyal Desheh is about to quit, Israeli press reports. 3 May 2017
Recently-floated PLx Pharma has made two new executive appointments, hiring Rita O’Connor as chief financial officer and Michael Dillon as vice president of sales and marketing. 3 May 2017
Dr Ellen Donnelly, former head of clinical operations of the neuroscience and pain therapeutic area at Pfizer, has been appointed as chief executive officer at Modus Therapeutics. 24 April 2017